SCHEMBL23329201

SCHEMBL23329201

O=C(NC1CCCCC1)c1cc(Cl)nc2[nH]ccc12

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.65
KMT2A Q03164 1/20 0.65
ALDH1A1 P00352 2/20 0.51
HTT P42858 1/20 0.51
APOBEC3G Q9HC16 1/20 0.51
RAB9A P51151 5/20 0.50
ADORA2A P29274 1/20 0.49
NPC1 O15118 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
MAPT P10636 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
ATM Q13315 1/20 0.46
HPGD P15428 1/20 0.46
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
CNR2 P34972 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23329131 0.81 CD38 (0.68)
SCHEMBL26398154 0.78 TNKS (0.52) GAAKMT2AALDH1A1HTTAPOBEC3G
SCHEMBL23329205 0.77 CD38 (0.71) ALDH1A1ADORA2ASMN1; SMN2KDM4ELMNA
SCHEMBL2158798 0.75 KDM4E (0.41) GAAKMT2AALDH1A1HTTADORA2A
SCHEMBL23329119 0.75 GAA (0.49) GAAKMT2AALDH1A1HTTAPOBEC3G
SCHEMBL17742333 0.75 HPGDS (0.47) GAAKMT2AMAPTKDM4E
SCHEMBL10110217 0.74 NUDT1 (0.43)
SCHEMBL2106151 0.72 JAK1 (0.65)
SCHEMBL1970134 0.72 SLC6A12 (0.62) GAAKMT2AALDH1A1HTTRAB9A
SCHEMBL31347077 0.72 KDM4E (0.58) ALDH1A1SMN1; SMN2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021087087-A1 N-CYCLOHEXYL-5-(THIAZOL-5-YL)-1H-INDOLE-7-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CD38 INHIBITORS FOR INCREASING NAD+ AND FOR THE TREATMENT OF E.G. MUSCULAR DISORDERS MITOBRIDGE INC. (US) 2021-05-06 WO disclosed